康恩貝(600572.SH)與浙江中醫藥大學簽訂戰略合作協議
格隆匯5月5日丨康恩貝(600572.SH)公佈,2022年4月29日,浙江康恩貝製藥股份有限公司和浙江中醫藥大學在杭州市濱江區濱康路568號康恩貝中心簽訂了《戰略合作協議》。
為更好地服務國家中醫藥發展戰略,圍繞浙江“打造生命健康科技創新高地、萬億健康產業和建設中醫藥強省”的戰略部署,雙方決定發揮各自優勢,整合資源,開展全面戰略合作,助推學校一流中醫藥大學建設,助力康恩貝打造浙江省中醫藥健康產業主平台,共同為健康浙江、健康中國的建設做出積極貢獻。
雙方的合作將突出中醫藥創新、聚焦中醫藥大健康發展,圍繞相關領域的科學研究、人才培養、產業發展、文化傳承等方面,開展多形式、多層次、多渠道的產學研合作,助力浙江建設中醫藥強省、打造萬億健康產業,引領全國中醫藥健康產業發展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.